At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 210 enrolled
Drug / intervention
Intravenous acetaminophen +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effect of IV Acetaminophen on Patients in the Neurocritical Care Unit
In Brief
A Phase 4 clinical trial evaluating Intravenous acetaminophen and Placebo for IV acetaminophen for Post-operative Craniotomy Patients and 4 related conditions. Completed, enrolled 210 participants across 1 site.
Detailed Summary
To assess the efficacy of an intravenous nonnarcotic pain medication on controlling patient pain. To assess the effect of an intravenous nonnarcotic pain medication on patient sedation levels in neurocritically ill patients. To assess the effect of an intravenous nonnarcotic pain medication on common side effects seen in patients taking other intravenous narcotic pain medication in the neurocritical care unit.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost-operative Craniotomy Patients, Carotid Endarterectomy and Carotid Artery Stenosis Patients, Post-op Spine Patients Admitted to the NCCU, Endovascular Patients Undergoing Intracranial Intervention, Traumatic Brain Injuries NPO for at Least 12 Hours
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartAug 2013
First PostedSep 2013
Primary CompletionNov 2016
TodayJul 2026
First PostedSep 23, 2013
Enrollment StartAug 1, 2013
Primary CompletionNov 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 12.8 years ago
Interventions
Intravenous acetaminophendrug
Placebo for IV acetaminophendrug